SUSLX
Price
$15.08
Change
+$0.08 (+0.53%)
Updated
Jan 30 closing price
Net Assets
13.57M
VFINX
Price
$560.68
Change
+$2.95 (+0.53%)
Updated
Jan 30 closing price
Net Assets
1.35T
Ad is loading...

SUSLX vs VFINX

Header iconSUSLX vs VFINX Comparison
Open Charts SUSLX vs VFINXBanner chart's image
Lazard US Sustainable Equity Open
Price$15.08
Change+$0.08 (+0.53%)
VolumeN/A
Net Assets13.57M
Vanguard 500 Index Investor
Price$560.68
Change+$2.95 (+0.53%)
VolumeN/A
Net Assets1.35T
SUSLX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SUSLX vs. VFINX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SUSLX is a Buy and VFINX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.35T vs. SUSLX (13.6M). VFINX pays higher dividends than SUSLX: VFINX (1.24) vs SUSLX (0.69). SUSLX was incepted earlier than VFINX: SUSLX (5 years) vs VFINX (48 years). SUSLX is a more actively managed with annual turnover of: 34.00 vs. VFINX (2.00). VFINX has a lower initial minimum investment than SUSLX: VFINX (0) vs SUSLX (2500). VFINX annual gain was more profitable for investors over the last year : 24.72 vs. SUSLX (7.11).
SUSLXVFINXSUSLX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years48 years-
Gain YTD3.5912.743131%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets13.6M1.35T0%
Annual Yield % from dividends0.691.2455%
Returns for 1 year7.1124.7229%
Returns for 3 years6.6533.8520%
Returns for 5 yearsN/A87.33-
Returns for 10 yearsN/A199.31-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FRST11.180.58
+5.47%
Primis Financial Corp
DBD43.460.80
+1.88%
Diebold Nixdorf
KDP32.240.38
+1.19%
Keurig Dr Pepper
AVAV171.980.70
+0.41%
AeroVironment
UBX2.14-0.10
-4.46%
Unity Biotechnology